This presumably contributes to the low relative levels of hCS/GH-V gene expression in JEG-3 cells and hence similarity to those detected in nonplacental tumor cells, where appropriate levels of regulatory factors are not available even when sequences were made accessible as with azadC and TSA treatments of MCF-7 cells. This evidence concerns the gene GH2 and neoplasm.